Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bongros-BMP vs Bio-oss for Alveolar Bone Regeneration
NCT01634308Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dibotermin alfa in Alveolar bone loss, sponsored by Daewoong Pharmaceutical. Started Jun 2010; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT01634308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634308.